Equity
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss
CVS Health AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss increased by 1.3% to $305.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 35.9%, from $476.00M to $305.00M. Over 5 years (FY 2020 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss shows an upward trend with a 213.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ4 2019
Last reportedQ1 2026May 6, 2026
Metric ID:
afs_debt_securities_unrealized_loss_12m_plus_accHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $6.00M | $22.00M | $103.00M | $148.00M | $439.00M | $614.00M | $1.11B | $1.20B | $1.50B | $808.00M | $826.00M | $799.00M | $446.00M | $580.00M | $476.00M | $396.00M | $307.00M | $301.00M | $305.00M |
| QoQ Change | — | +500.0% | +266.7% | +368.2% | +43.7% | +196.6% | +39.9% | +80.0% | +9.0% | +24.7% | -46.2% | +2.2% | -3.3% | -44.2% | +30.0% | -17.9% | -16.8% | -22.5% | -2.0% | +1.3% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | +972.8% | +713.5% | +241.9% | +31.6% | -25.2% | -33.6% | -70.3% | -28.2% | -42.4% | -50.4% | -31.2% | -48.1% | -35.9% |
Range$1.00M – $1.50B
CAGR+233.4%
Avg YoY Growth>999%
Median YoY Growth-26.7%
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss at Other Companies
Frequently Asked Questions
- What is CVS Health's afs and trading securities - unrealized loss position (>=12 months) accumulated loss?
- CVS Health (CVS) reported afs and trading securities - unrealized loss position (>=12 months) accumulated loss of $305.00M in Q1 2026.
- How has CVS Health's afs and trading securities - unrealized loss position (>=12 months) accumulated loss changed year-over-year?
- CVS Health's afs and trading securities - unrealized loss position (>=12 months) accumulated loss decreased by 35.9% year-over-year, from $476.00M to $305.00M.
- What is the long-term trend for CVS Health's afs and trading securities - unrealized loss position (>=12 months) accumulated loss?
- Over 5 years (2020 to 2025), CVS Health's afs and trading securities - unrealized loss position (>=12 months) accumulated loss has grown at a 213.1% compound annual growth rate (CAGR), from $1.00M to $301.00M.